The Only Honest Part

Confessions in Small Font from KKR

FSK reported Q1 on May 11, 2026. NAV fell 9.9% to $18.83. Net loss of $1.57 per share. The dividend was cut to $0.42 — the second cut in four months, after the February cut from $0.70. Forty percent of the dividend, gone, in 120 days.

Moody’s cut FSK to junk in March. Fitch cut it to junk eight days later. Investors filed suit. The 10-Q dropped the same day KKR put a $600 million sponsor-support package on the table — $150 million in convertible preferred, $150 million in a tender at $11.00 (a 42% discount to NAV), $300 million in buyback authorization, and a 50% incentive-fee waiver for four quarters. The press is calling it a vote of confidence.

---

The headline numbers — the dividend cut, the NAV decline, the junk downgrades, the lawsuits, the KKR rescue package — are what you can see from the press release.

But there is more in the footnotes.

A footnote is a confession in a small font. In a Business Development Company filing, every loan in the Schedule of Investments carries a cluster of letters next to it. (z) means the loan is on non-accrual — the borrower stopped paying and the lender stopped pretending. (y) means the security is non-income-producing. (ad) means the lender now controls the borrower — equity, board, the keys.

The letters are not optional. They are the BDC equivalent of a doctor writing malignant in the chart. You do not get to take it back.

Unless you do.

Case 1 — Reliant Rehab Hospital Cincinnati

Two first-lien loans in the same Q1 filing. Same coupon: 6.3%. Same maturity: February 2028. Same lien position. One marked at 100 cents. The other marked at 21 cents, on (z).

A hospital that cannot service one 6.3% coupon cannot service the other. The filing contradicts itself in plain sight. The clean tranche keeps generating income for the dividend. The other one, the truth, gets the footnote. They picked which loan to lie about by tranche and the “agreement among lenders” is invisible.

Case 2 — Medallia

Thoma Bravo SaaS LBO, customer experience software being eaten by AI. December 2025: rate cell read “4.0% PIK / 4.0% PIK.” Footnote: (v). FSK was accruing payment-in-kind interest as income. The income funded the dividend.

March 2026: the PIK is gone from the rate cell. Footnotes: (v) (y) (z). Mark fell from 79 cents to 54 cents. The “income” stopped existing the same quarter the loan got marked down by exactly the kind of money the income wasn’t.

Case 3 — KKR Central Park Leasing Aggregator

ABF equity. December 2025 footnotes: (ad) (v) (w) (y) (z) — the full house. March 2026 footnotes: (ad) (v) (w) (y). The (z) is gone. Fair value: $27.0 million in both quarters. The price did not move, but the non-accrual flag did.

A loan does not get healthier without getting more valuable. The footnote was scrubbed.

Case 4 — Affordable Care

Berkshire Partners dental DSO. Two first-lien tranches and a preferred — all three positions flipped to (y) (z) in the same quarter. The preferred wrote down $70.6 million toward zero. Bloomberg reported on April 22 that KKR, Blackstone, Antares, and New Mountain were restructuring AC’s $1.4 billion private credit loan after EBITDA collapsed. KKR is the manager of FSK. The footnote diff caught what the press release would not say.

Case 5 — Constellis

Apollo’s security contractor. Blackwater. Triple Canopy. ACADEMI. Three corporate names in twenty years; that is its own kind of footnote. The 2L mark fell from 88 cents to 29 cents in 90 days. Newly (y) (z). The third blow-up.

Case 6 — Kellermeyer Bergensons

Same borrower, two PIK tranches in the Q1 filing. The 8% PIK got the (z). The 5.3% PIK did not. Same company. Same business. Selective non-accrual by tranche, by basis point. The lender chose where to admit the loss.

---

The Street will spend the next quarter arguing whether the $600 million sponsor support package, the buyback, the fee waiver, and the convertible preferred add up to a floor. Whether non-accruals at 8.1% are a peak or a way station. Whether the NAV discount of 42% is a margin of safety or a starting point.

These are the wrong arguments.

The right argument is whether a fund whose footnotes can be removed without explanation, whose identical tranches of the same hospital are marked at 100 cents and 21 cents, whose PIK income vanishes from the rate cell the same quarter the loan goes on non-accrual, has a number underneath it that means anything at all.

A BDC accrues PIK as income. The income funds a dividend. The next quarter the loan is marked down by that PIK, plus more. The cycle does not break. It is recognized. The dividend cuts on February 19 and May 6 were the recognition. The 10-Q filed on May 11 was the paperwork. The footnotes were the receipts.

The footnotes are the only honest part of the filing.
The ones that disappear are the ones that mattered most.